🇺🇸 FDA
Patent

US 9359437

Antibodies comprising chimeric constant domains

granted A61PA61P43/00

Quick answer

US patent 9359437 (Antibodies comprising chimeric constant domains) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P43/00